Key Takeaways

The U.S. Food and Drug Administration is expected to approve a new HIV shot this monthA study showed the injection prevented all HIV cases in women and girlsThe drug’s maker hopes the new shot will expand HIV prevention across the globe

FRIDAY, June 6, 2025 (HealthDay News) — A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.

If approved, the shot — lenacapavir — would be given twice a year and could be a big step forward in the fight against HIV.

Drugmaker Gilead Sciences tested the shot in a study of women and girls. None of the participants who received the injections got HIV.

That early success helped boost Gilead’s stock by 73% over the past year, The Wall Street Journal reported.

“We kno

See Full Page